globus medical stock forecast

DUBLIN February 16 2022--BUSINESS WIRE--The Bone Grafts and Substitutes. GMED reported fourth-quarter 2021 adjusted earnings per share EPS of 49 cents beating the Zacks Consensus Estimate by 21.

Estimating The Fair Value Of Globus Medical Inc Nyse Gmed Nasdaq

Evonik Industries AG Zimmer Biomet Globus Medical Stryker DSM Biomedical Invibio Ltd CAM Bioceramics BV DePuy Synthes Inc Matexel and Exactech Inc among others.

. Becton Dickinson and Stock Forecast Price News 26874-731 -265 As of 0382022 0252 PM ET. The global market for bone graft and substitutes should grow from 8 billion in 2021 to 115 billion by 2026 with a compound annual growth rate CAGR of 76 for the period of 2021-2026. The medical instruments supplier reported 364 earnings per share for the quarter topping analysts consensus estimates of 285 by 079.

23022022 - Fourth quarter total revenue was 4320 million up 160 year-over-year enabled by a wide open network designed to serve all Medicare lives Lives under Clover Assistant Management. The report covers an extensive analysis of the key market players in the market along with their business overview expansion plans and strategies. The medical instruments supplier had revenue of 5 billion for the quarter compared to analysts.

Globus Medical Inc. However the metric lagged the year-ago adjusted. I want to turn off radiators in rooms that I dont use to save energy and money.

But Im worried that the cooler rooms will drain warmth from the parts of the house I do heat. The report also focuses.

Gmed Stock Price And Chart Nyse Gmed Tradingview